KRAS and neoplasm: Consistently, conditional deletion of Hnf4a in genetically engineered mouse models (GEMMs) with Kras-driven, Trp53-deleted LUAD tumors resulted in significantly reduced tumor growth and decreased tumor cell proliferation, highlighting the importance of Hnf4a for LUAD growth in vivo.